Tissue-derived stem cells (TDSCs) have proven to be a feasible source of cells for tissue regeneration medicine in recent experimental and clinical studies. TDSCs are presented in tissues such as bone marrow (BM), blood vessels, adipose tissues, and placental and dental pulp for repairing damaged areas by generation of new cells and tissues. Mesenchymal stem cells (MSCs) are multipotent stem cells, reported to present plastic adherence and different abilities in endodermal, mesodermal, and ectodermal cells and immunoregulatory property potential in cell-based therapies and regenerative medicine. To better understand TDSCs, we opened up the special issue focused on TDSCs in 2016 and pushed forward an annual issue in 2019 including recent findings concerning TDSCs.
In the special issue, 16 selected papers including 13 research papers and 3 review papers were published. strategies that have been adopted to improve cell grafting and track cells after transplantation. F. Sallustio et al. analyzed many different functions that the Toll-like receptors (TLRs) assume in stem/progenitor cells, pointing out that they can have different effects, depending on the background and the kind of ligands that they recognize. They also discussed the TLR involvement in the response of stem cell to specific tissue damage.
We hope that the annual special issue provided insights into TDSCs such as MSCs and speeds up their clinical application in regenerative trials in the near future.
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